Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (FR 3628/2-1)
Text and Data Mining valid from 2019-06-11
Received: 10 February 2019
Accepted: 20 May 2019
First Online: 11 June 2019
: S.W., M.K. and T.F. are inventors and beneficiaries of a patent held by Technical University of Munich covering the use of FGF8 to treat metabolic disease (WO2015121457A1). Beyond, all authors declare the absence of competing interest.